Donors commit historic vaccine funding

Major public and private donors have achieved a milestone in global health by committing historic levels of funding to deliver vaccines to more than 250 million of the world’s poorest children. At Monday’s pledging conference hosted by the GAVI Alliance in London, donors committed $4.3 billion, exceeding GAVI’s initial target of $3.7 billion for the conference, to deliver lifesaving vaccines against global health diseases. Leaders also stressed the need to support research for vaccines that do not yet exist, including for diseases such as HIV and malaria, in order to save even more lives in the future.

Read more

Researchers cite progress and momentum on HIV/AIDS

To mark the recent 30th anniversary of the discovery of HIV/AIDS, scientists and researchers have cited recent progress and momentum in developing new treatment and prevention tools. For example, scientists and advocates have been focusing on developing a safe and effective HIV vaccine, particularly as increased access to effective therapies has turned HIV/AIDS into a chronic disease and treatment costs have increased.

Read more 

Agency spotlight: USPTO

In an effort to encourage innovations for global health and other issues, the US Patent and Trademark Office (USPTO) is implementing a pilot program to use the patent review system to spark the development and delivery of technologies that address humanitarian needs. Prize winners will receive a voucher for fast-track patent review that can be transferred on the open market.

Read more

Photos (top to bottom): Nguyen Ba Quang, Mike Wang, Satvir Malhotra

June 2011

UPCOMING EVENTS

June 19-21, 2011
Global Health Research Congress

June 22-23, 2011
Small business innovation research & small business technology transfer 2011 conference

June 27-30, 2011
Partnering for Global Health

June 30, 2011
Staying the Course: Malaria R&D in a Changing World

July 8-10, 2011
International Society for Infectious Diseases neglected tropical diseases meeting

NEW AND NOTEWORTHY

JAMA article highlights GHTC report on US funding for new global health tools

Former Congressman calls for bipartisan support for medical research

Video now available for GHTC event highlighting the need for new vaccines

Global health technologies can “make the difference between life and death,” Congressman writes

Dramatic decrease in meningitis recorded in West Africa following new vaccine introduction

Scientists and advocates launch vaccine research foundation

Health Affairs issue highlights vaccines, features articles by GHTC members

Grand Challenges program elicits more than 600 innovations to benefit pregnant women and newborns worldwide

New article highlights momentum in tuberculosis vaccine development
 

MEMBER FOCUS

The pharmaceutical company Sanofi and GHTC member the Drugs for Neglected Diseases initiative (DNDi) have announced a three-year research agreement for the research of new treatments for nine neglected tropical diseases.

Read more

Received this as a forward? Click here to sign up for future issues.

If you wish to unsubscribe, please click here to send us a message. We will remove your name from our mailing list as soon as possible.

The Global Health Technologies Coalition (GHTC) is a group of almost 40 nonprofit organizations working to increase awareness of the urgent need for tools that save lives in the developing world. These tools include new vaccines, drugs, microbicides, diagnostic tests, and other devices. The coalition advocates for increased and effective use of public resources, incentives to encourage private investment, and streamlined regulatory systems. Learn more at www.ghtcoalition.org.

To see a list of GHTC members, click here.

We respect the privacy of our online relationships. our mailing lists are never sold to third parties. We will only share personally identifiable information with third parties when the person submitting the information authorizes us to share it or we are required to by law.